Cell Therapy News Volume 22.38 | Nov 1 2021

    0
    40







    2021-11-01 | CTN 22.38


    Cell Therapy News by STEMCELL Technologies
    Vol. 22.38 – 1 November, 2021
    TOP STORY

    CITED2 Coordinates Key Hematopoietic Regulatory Pathways to Maintain the HSC Pool in Both Steady-State Hematopoiesis and Transplantation

    While hematopoietic-specific Cited2 deletion has a minor impact on steady-state hematopoiesis, Cited2-deficient hematopoietic stem cells are severely depleted in young mice and fail to expand upon aging.
    [Stem Cell Reports]

    Full Article
    Find the Right Antibodies for Your Stem Cell Research. Learn More
    PUBLICATIONSRanked by the impact factor of the journal

    Transplant of Autologous Mesenchymal Stem Cells Halts Fatty Atrophy of Detached Rotator Cuff Muscle After Tendon Repair: Molecular, Microscopic, and Macroscopic Results From an Ovine Model

    The authors investigated whether the injection of autologous mesenchymal stem cells halted muscle-to-fat conversion after tendon repair in a large animal model for rotator cuff tendon release via regional effects on extracellular fat tissue and muscle fiber regeneration.
    [American Journal of Sports Medicine]

    Full Article

    Peripheral Leukemia Burden at Time of Apheresis Negatively Affects the Clinical Efficacy of CART19 in Refractory or Relapsed B-ALL

    Scientists retrospectively analyzed 143 patients treated with CART19 to evaluate the effect of peripheral leukemia burden at time of apheresis.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull ArticleGraphical Abstract

    Quantification of Cell-Free DNA for the Analysis of CD19-CAR-T Cells during Lymphoma Treatment

    Cell-free DNA isolated from 74 blood samples of 12 patients during lymphoma treatment with the anti-CD19 CAR-T cell product axicabtagene ciloleucel were analyzed.
    [Molecular Therapy-Methods & Clinical Development]

    AbstractFull ArticleGraphical Abstract

    Neuroinflammation in Primary Cultures of the Rat Spinal Dorsal Horn Is Attenuated in the Presence of Adipose Tissue–Derived Medicinal Signaling Cells (AdMSCs) in a Co-Cultivation Model

    Researchers applied the recently established mixed neuroglial primary cell culture of the rat superficial dorsal horn (SDH) to investigate effects of adipose mesenchymal stem cells on the inflammatory response of SDH cells.
    [Molecular Neurobiology]

    Full Article

    Therapeutic Effects of Acylated Ghrelin-Specific Receptor GHS-R1a Antagonist in Islet Transplantation

    Investigators elucidated whether regulation of growth hormone secretagogue receptor-1a (GHS-R1a), one of the ghrelin receptors, improved the therapeutic effects of islet transplantation using -GHRP-6, a specific GHS-R1a antagonist.
    [Scientific Reports]

    Full Article

    Deferoxamine Preconditioning Enhances the Protective Effects of Stem Cells in Streptozotocin-Induced Alzheimer’s Disease

    After induction of the Alzheimer’s disease model, the rats were transplanted with deferoxamine-preconditioned adipose-derived mesenchymal stem cells or untreated cells.
    [Life Sciences]

    Abstract

    Association Study of Candidate DNA-Repair Gene Variants and Acute Graft versus Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem-Cell Transplantation

    Scientists explored 51 variants within 17 DNA-repair genes for their association with acute graft versus host disease grades two–four in 60 pediatric patients.
    [Pharmacogenomics Journal]

    Full Article

    Human Liver Stem Cell Transplantation Alleviates Liver Fibrosis in a Rat Model of CCl4-Induced Liver Fibrosis

    Investigators introduced a rat model of liver fibrosis and trans-portal transplantation of human liver stem cells to demonstrate alleviation of liver fibrosis.
    [International Journal of Stem Cells]

    Abstract

    Dr. Kristina McBurney and Leanna Bedell discuss how you can use social media to advance your scientific career. Watch now.
    REVIEWS

    Engineered Antibody Fusion Proteins for Targeted Disease Therapy

    Scientists focus on recent engineering and translational advances for therapeutics that genetically fuse antibodies to disease-relevant payloads, including cytokines, toxins, enzymes, neuroprotective agents, and soluble factor traps.
    [Trends in Pharmacological Sciences]

    Abstract

    Type 1 Conventional Dendritic Cells: Ontogeny, Function, and Emerging Roles in Cancer Immunotherapy

    The authors review the progress in defining the key developmental and functional attributes of type 1 conventional dendritic cells (cDC1s) and the approaches to optimizing the potency of cDC1s for anticancer immunity.
    [Trends in Immunology]

    Abstract

    Non-Invasive Cell-Tracking Methods for Adoptive T Cell Therapies

    Investigators provide a concise overview of the main principles and potential of cell tracking, followed by a discussion of the clinically relevant labeling strategies and their application in adoptive T cell therapies (ACT).
    [Drug Discovery Today]

    Abstract
    INDUSTRY AND POLICY NEWS

    Talaris Therapeutics Announces First Patient Dosed in Phase III Clinical Trial of FCR001 in Living Donor Kidney Transplant Recipients

    Talaris Therapeutics, Inc. announced that the first patient has been dosed in the FREEDOM-1 Phase III clinical trial of FCR001 in living donor kidney transplant recipients.
    [Talaris Therapeutics, Inc.]

    AbstractPress Release

    King’s Spin Out Leucid Bio Wins Funding Boost for CAR-T Therapies

    Work led by Dr. John Maher at the School of Cancer & Pharmaceutical Sciences and in Leucid Bio sees the team genetically reprogram T cells to recognise and destroy cancer cells. This is done by inserting a gene that enables the T cell to make a new protein called a CAR.
    [King’s College London]

    Press Release
    FEATURED EVENT

    > See All Events

    JOB OPPORTUNITIES

    Scientist – Gene Therapy Research

    Sarepta Therapeutics, Inc. – Columbus, Ohio, United States

    Postdoctoral Research Fellow – Tumor Microenvironment

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    Director – Liver Biology

    Gordian Biotechnology – San Francisco, California, United States

    Associate Professor – Translational Skin Cancer

    Columbia University Medical Center – New York, New York, United States

    Postdoctoral Fellow – Cancer Immunology & Stem Cell Engineering

    Hong Kong University – Hong Kong, China

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter